combined effects of acbt and autogenic drainage in patients with chronic obstructive pulmonary disease

Conditions: Chronic Obstructive Pulmonary Disease

Summary: a randomised controlled trial will be conducted with copd patients as its target population. there will be 40 individuals for both the control group and the intervention group. group a is a control group while group b is an experimental group (20 participants on group a and 20 on group b). the baseline treatment for both groups were pursed lip breathing and acbt. on the other hand, group b experimental group will also undergo (pursued lip breathing and acbt) with autogenic drainage. group a session lasts for 30 minutes and group b session lasts for 45 minutes. there is only one session per day. there is a three session in a week for 4 weeks. measurements are made of dyspnea, oxygen saturation, peak expiratory flow rate, pulse rate and fatigue both before and after the treatment, data were recorded. participants in the trial must have mild to moderate copd (gold criteria) and be between the ages of 40 to 60 years. data from sheikh zayed hospital, rahim yar khan will be collected. follow-up for both completed tasks and changes in pulmonary status will be evaluated after 4 weeks. modified borg dyspnea (rpe) scale, breathlessness, cough and sputum scale (bcss), fatigue severity scale or visual analogue scale, peak flow meter, oximeter will be used to measure the outcomes. data will be analysed using the spss 21.0 statistical software

the term "copd" refers to a range of illnesses that impair breathing and obstruct airflow. smoking or having smoked in the past increases the risk of developing copd because tobacco smoke is the primary cause of the disease. the risk is further increased by family history, occupational or home, air pollution exposure and respiratory illnesses including pneumonia. the signs and symptoms include wheezing, coughing up mucus (sputum) and difficulty in breathing. it is frequently brought on by prolonged exposure to irritant gases or particulates most frequently from cigarette smoke. heart disease, lung cancer and a number of other diseases are more likely to occur in people with copd. a randomised controlled trial will be conducted with copd patients as its target population. there will be 40 individuals for both the control group and the intervention group. group a is a control group while group b is an experimental group (20 participants on group a and 20 on group b). the baseline treatment for both groups were pursed lip breathing and acbt. on the other hand, group b experimental group will also undergo (pursued lip breathing and acbt) with autogenic drainage. group a session lasts for 30 minutes and group b session lasts for 45 minutes. there is only one session per day. there is a three session in a week for 4 weeks. measurements are made of dyspnea, oxygen saturation, peak expiratory flow rate, pulse rate and fatigue both before and after the treatment, data were recorded. participants in the trial must have mild to moderate copd (gold criteria) and be between the ages of 40 to 60 years. data from sheikh zayed hospital, rahim yar khan will be collected. follow-up for both completed tasks and changes in pulmonary status will be evaluated after 4 weeks. modified borg dyspnea (rpe) scale, breathlessness, cough and sputum scale (bcss), fatigue severity scale or visual analogue scale, peak flow meter, oximeter will be used to measure the outcomes. data will be analysed using the spss 21.0 statistical software.

Eligibility criteria:
inclusion criteria: * both genders (male and female) * age 40 to 60 years * mild to moderate copd (according to gold criteria) * patient is bilingual. exclusion criteria: * patients having progressive respiratory muscle weakness (mysthenia gravis) * cardiovascular impairment * any recent surgery * systemic illness * angina * uncontrolled diabetes and hypertension * tb * non-cooperative patients

Keywords: chronic obstructive drainage postural pulmonary disease respiratory therapy.